Skip to main content
Education & Inspiration

Ask the MD

To help you and your loved ones navigate life with Parkinson's, a movement disorder specialist discusses Parkinson's research and care through blogs and videos.

Dr. Rachel Dolhun.

Meet Dr. Dolhun

Rachel Dolhun is a fellowship-trained movement disorder specialist, board-certified neurologist and vice president of medical communications at The Michael J. Fox Foundation.


  • New Data on Extended-Release Amantadine for Dyskinesia

    Ask the MD: Does Parkinson’s Have a Signature Scent?

    Scientists have identified a characteristic scent on the skin of people with Parkinson’s disease. This may be a tool for earlier and easier diagnosis.

  • WSJ: New Results Suggest Deep Brain Stimulation Benefits Psychiatric Conditions

    Ask the MD: Stimulating the Brain to Treat Parkinson’s

    Non-invasive brain stimulation is a promising potential tool to treat Parkinson’s motor and non-motor symptoms.

  • hospital and pd.png

    Ask the MD: Being in the Hospital with Parkinson’s

    Being in the hospital — for any reason — can temporarily worsen Parkinson’s symptoms. Learn steps to make hospital visits, if they happen, as safe and productive as possible.

  • Ask the MD: Parkinson’s Disease and Melanoma

    Ask the MD: Melanoma and Parkinson’s Disease

    People with Parkinson’s are at risk for the skin cancer melanoma. Learn how to limit risk and how researchers study melanoma and Parkinson’s to better understand and treat both diseases.

  • Better Brain Health

    New Guide: Better Brain Health

    Our new resource offers information and easy-to-follow tips to boost brain health and to limit risk for brain disease, like Parkinson’s.

  • How to Find the Right Doctor for Parkinson's Treatment

    Ask the MD: New Parkinson’s Treatment Submitted to FDA for Approval

    A new levodopa formulation — an under-the-skin, continuous infusion — is making its way toward possible approval.

"Thanks for sharing. Will keep these useful tips in mind."
Pujah Ohri via Facebook
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.